November 2010- Volume 6, Issue 11

November 2010

In this Issue

New Products

Round bottom tube for critical cellular applications

Round bottom tube for critical cellular applications

Thermo Fisher Scientific Inc. has introduced a new Thermo Scientific Nunc 14 ml round bottom tube for critical cellular applications.

Feature

Come to Philly to see how far cell biology has come

Come to Philly to see how far cell biology has come

Marking off a half century of annual meetings and even longer for cell biology scientific progress, the ASCB brings it all together in the ‘City of Brotherly Love’

Research & Development

Companies seek game-changer for CKD

Companies seek game-changer for CKD

Reata, Abbott team up to develop, commercialize bardoxolone methyl to treat chronic kidney disease

Following the natural laws of economics

Following the natural laws of economics

Endo Pharmaceuticals acquires generics giant Qualitest to be more responsive to changing healthcare environment

Oncology trifecta

Oncology trifecta

Having signed recent deals with two other top cancer-focused companies, ImmunoGen announces collaboration with Novartis for rights to use TAP Technology

One down, two to go

One down, two to go

LabCorp enters into definitive agreement to acquire Genzyme Genetics, one of three business units that Genzyme is aiming to offload

Pfizer adds pain jewels to crown

Pfizer adds pain jewels to crown

Staking its claim as a leader in the pain relief market, Pfizer acquires King Pharmaceuticals for $3.6 billion

Government Watch

Overseas drug deals interest the feds

Overseas drug deals interest the feds

U.S. drug companies investigated for possible bribes

To disclose or not to disclose?

To disclose or not to disclose?

U.S. Supreme Court to hear arguments in shareholder lawsuit against Matrixx over drug Zicam; decision could impact adverse effect reporting requirements

FDA hosts hearing on biologics issues

FDA hosts hearing on biologics issues

Agency seeks input on implementation of Biologics Price Competition and Innovation (BPCI) Act

Stem cell debate plays out in court

Stem cell debate plays out in court

After a federal court halts Obama administration’s expansion of embryonic stem cell research, an appellate court OKs government funding—for now

Diagnostics

Winning the hand of the girl next door

Winning the hand of the girl next door

Combination of MorphoSys and Sloning technologies set to increase success rates in drug development

Cepheid forms collaboration with Novartis

Cepheid forms collaboration with Novartis

Deal focuses on commercialization of test to monitor the BCR-ABL gene transcript in peripheral blood specimens related to Ph+ chronic myelogenous leukemia

A crystal ball for cancer

A crystal ball for cancer

Roche, German Cancer Research Center enter research agreement to predict cervical cancer

Getting it right the first time

Getting it right the first time

Sirius Genomics and Golden Helix collaborate on sepsis diagnostic development

Instruments & Informatics

Three-way triple threat

Three-way triple threat

Vivo Biosciences, ACEA Biosciences and Roche to develop xCELLigence System assays for stem cell and cancer research

Capture and release

Capture and release

IDBS and Genomic Health team up to streamline development of oncology diagnostic tools

A sunny solution

A sunny solution

Cisbio partners with Blue Sky to target kinases

Diaceutics and London Genetics to develop software for biomarker studies

Diaceutics and London Genetics to develop software for biomarker studies

New product to be launched in 2011 will be based on the Diaceutics Fusion and London Genetics Biomarker Pathway platforms

Omics & Systems Biology

Takeda and Envoy form schizophrenia research alliance

Takeda and Envoy form schizophrenia research alliance

Deal calls for $3 million upfront and $2.25 million per year over three years

Going with the flow

Going with the flow

Thermo Fisher Scientific and Proteome Sciences cement ongoing protein biomarker collaboration

The eyes have it

The eyes have it

RXi Pharmaceuticals and EyeGate Pharma see a future together focused on retinal therapies

Domo arigato

Domo arigato

Germany’s Kinaxo signs cancer research agreement with Japan’s Daiichi Sankyo

Patent News

Practicing an industry standard may be basis for patent infringement

Practicing an industry standard may be basis for patent infringement

The Federal Circuit recently affirmed that an admission that an accused infringing device practicing an industry standard may, without more, be the basis for a finding of infringement.

Commentary

Guest Commentary: Bioproduction goes global

Guest Commentary: Bioproduction goes global

Biopharmaceuticals, including monoclonal antibodies and vaccines, make up an increasingly large proportion of drugs on the market and in the development pipeline.

Global News

Mimicry with real results

Mimicry with real results

Sanofi Pasteur to acquire U.S. biotech company VaxDesign and advance its MIMIC technology

An orthogonal collaboration

An orthogonal collaboration

Evotec and Shionogi partner in fragment-based drug discovery program

Partners take it to the next level

Partners take it to the next level

Previous partners Janssen Pharmaceutica and Argenta enter into integrated cancer drug discovery service agreement

What once was lost could be found

What once was lost could be found

AstraZeneca & UCL collaborate on stem cell solution to diabetic vision loss

One giant step for Covance … and perhaps other CROs

One giant step for Covance … and perhaps other CROs

Covance secures $2.2 billion R&D alliance with sanofi-aventis that may signal a market shift toward outsourcing more pharma services

Editor's Focus

A new medium, a new message

A new medium, a new message

Controversy is a curious thing, especially when you throw today’s communication technology into the mix. Everybody has an opinion about everything, and takes to a keyboard to share it with the world.

Special Reports

Knowledge is power

Knowledge is power

Breakthroughs in cancer research are frequently pioneered in the halls of academia

Federal funding and the 40 years’ war on cancer

Federal funding and the 40 years’ war on cancer

Government bureaucracy may be thwarting funding of breakthrough cancer research
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

January 2024 DDN Magazine Issue

Latest Issue  

• Volume 20 • Issue 1 • January 2024

January 2024

January 2024 Issue